Skip to main content

Mizuho Securities Keeps Their Buy Rating on SunOpta (STKL)

Tipranks - Tipranks - Thu Jan 15, 1:20AM CST

In a report released yesterday, John Baumgartner from Mizuho Securities maintained a Buy rating on SunOpta. The company’s shares closed yesterday at $4.49.

Claim 70% Off TipRanks Premium

Baumgartner covers the Consumer Defensive sector, focusing on stocks such as Primo Brands, UTZ Brands, and Herbalife. According to TipRanks, Baumgartner has an average return of 5.2% and a 51.68% success rate on recommended stocks.

SunOpta has an analyst consensus of Strong Buy, with a price target consensus of $8.00.

See today’s best-performing stocks on TipRanks >>

Based on SunOpta’s latest earnings release for the quarter ending September 27, the company reported a quarterly revenue of $205.41 million and a net profit of $816 thousand. In comparison, last year the company earned a revenue of $176.22 million and had a GAAP net loss of $5.5 million

Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of STKL in relation to earlier this year. Most recently, in November 2025, Gaba Greg, the CFO of STKL bought 15,000.00 shares for a total of $50,850.00.

Read More on STKL:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).